Results 111 to 120 of about 13,103,023 (178)

Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B

open access: yes, 2010
BACKGROUND & AIMS: Inconsistencies in results and guideline recommendations regarding the durability of nucleos(t)ide analogue-induced hepatitis B e antigen (HBeAg) seroconversion require clarification.
Janssen, HLA   +9 more
core   +1 more source

Durability of response after hepatitis B surface antigen seroclearance during nucleos(t)ide analogue treatment in a multiethnic cohort of chronic hepatitis B patients : results after treatment cessation

open access: yes, 2017
: In 70 chronic hepatitis B patients with hepatitis B surface antigen seroclearance during nucleos(t)ide analogue therapy, response was sustained in all 54 patients who discontinued treatment.
Peng, Jie   +33 more
core   +1 more source

Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts. [PDF]

open access: yesAntiviral Res, 2023
Dsouza L   +7 more
europepmc   +1 more source

2′-β-Methylselenyl nucleos(t)ide analogs as reverse transcriptase inhibitors against diverse HIV mutants

open access: yesBioorganic & Medicinal Chemistry
Nucleoside reverse transcriptase inhibitors (NRTIs) have been extensively studied as drugs targeting HIV RT. However, the practice or use of approved NRTIs lacking the 3'-hydroxy group often promotes frequent HIV mutations and generates drug-resistance. Here, we describe a novel NRTI with 2'-β-methylselenyl modification. We found that this modification
Yuki, Yoshida   +13 more
openaire   +2 more sources

Therapy with nucleos(t)ide analogues: current role in dialysis patients

open access: yes, 2010
Hepatitis B virus (HBV) infection persists among patients undergoing maintenance dialysis in the industrialized world. Knowledge of the epidemiology and the natural history of HBV infection in dialysis patients has markedly improved but antiviral therapy
Dixit V   +11 more
core   +1 more source

Review article : The potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection

open access: yes, 2016
Background: A short-term course of pegylated-interferon (Peg-IFN), or a long-term treatment with a third generation nucleot(s)ide analogue (NUC), of chronic hepatitis B (CHB) infection achieves viral suppression and may prevent disease progression. Owing
M. Viganò   +3 more
core   +1 more source

The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis

open access: yes, 2018
The application of nucleos(t)ide analogues in hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) has not yet been widely accepted. Therefore, we conducted a meta-analysis of prospective and retrospective studies to examine the efficacy
Zhi Chen   +8 more
core  

The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis. [PDF]

open access: yesFront Public Health, 2021
Wen X   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy